Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ponatinib in CML and Ph+ ALL: balancing high efficacy with vascular safety.

Postgraduate medicine·2026
Same author

Disparities in oral cancer screening among Indian women aged 30-49: insights from a national survey.

Ecancermedicalscience·2026
Same author

Geospatial mapping, risk assessment and multivariate analysis of naturally occurring radionuclides and potentially toxic elements in agrarian soils of SAS Nagar, Punjab, India.

Scientific reports·2026
Same author

Uncovering the biosynthetic potential of Amycolatopsis: new insights into glycopeptide antibiotic and polyketide gene clusters.

Journal of applied microbiology·2026
Same author

Fluoroquinolone Prophylaxis Uncovers High Prevalence Rates of Fluoroquinolone-Resistant <i>Enterobacterales</i> Colonization in Multiple Myeloma Autologous Transplant Patients: A Prospective Cohort Study.

Cancers·2026
Same author

Adaptive evolution of gene regulatory networks in mammalian neocortex.

Nature·2026

Related Experiment Video

Updated: Jul 8, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Nanotechnology to Break the Antimicrobial Resistance.

Navjot Kaur1, Pragnya Roy1, Mrinmoy De1

  • 1Department of Organic Chemistry, Indian Institute of Science, Bangalore 560012, India.

ACS Infectious Diseases
|July 6, 2026
PubMed
Summary

New nanomaterials offer promising strategies against antibiotic resistance. This review explores how nanomaterial design, including size and surface chemistry, impacts their effectiveness against multidrug-resistant pathogens.

Keywords:
antibacterial activityantibacterial mechanismantibiofilm activityantimicrobial resistancenanomaterials

More Related Videos

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects
06:42

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects

Published on: September 27, 2024

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
08:08

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Published on: August 4, 2018

Related Experiment Videos

Last Updated: Jul 8, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects
06:42

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects

Published on: September 27, 2024

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications
08:08

Antimicrobial Characterization of Advanced Materials for Bioengineering Applications

Published on: August 4, 2018

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Infectious Diseases

Background:

  • Antibiotic resistance is a growing global health crisis, necessitating novel treatments for multidrug-resistant (MDR) infections.
  • Nanomaterials present unique properties and mechanisms of action distinct from traditional antibiotics, making them promising therapeutic candidates.
  • Surface-modified nanomaterials and metal-organic cages are emerging as key players in antimicrobial research.

Purpose of the Study:

  • To review the role of surface-modified nanomaterials and metal-organic cages in combating antibiotic resistance.
  • To analyze how nanomaterial characteristics influence antibacterial and antibiofilm efficacy.
  • To bridge mechanistic understanding with biological context for practical applications.

Main Methods:

  • Literature review focusing on surface-modified nanomaterials and metal-organic cages.
  • Analysis of structure-activity relationships, including size, charge, and surface chemistry.
  • Integration of mechanistic insights with biological context of infection environments.

Main Results:

  • Nanomaterial properties like size, charge, and surface chemistry significantly impact antibacterial and antibiofilm performance.
  • Distinct mechanisms of action offer advantages over conventional antibiotics against MDR pathogens.
  • Understanding these factors is crucial for optimizing nanomaterial-based antimicrobial strategies.

Conclusions:

  • Nanomaterial design offers a powerful framework for developing advanced antimicrobial therapies.
  • Addressing translational challenges is key to the clinical application of these novel agents.
  • Further research integrating design principles with infection biology will accelerate the development of effective solutions.